Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity

Documenti analoghi

• 5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
  di: Jianhua Xia, et al.
  Pubblicazione: (2024)
• Targeting the Ubiquitin–Proteasome System for Cancer
  di: Zhaoyun Liu, et al.
  Pubblicazione: (2025)
• Midnolin Ubiquitination is Required for its Proteasome‐Mediated Degradation
  di: Jiang He, et al.
  Pubblicazione: (2025)
• Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
  di: Nanzhi Luo, et al.
  Pubblicazione: (2025)
• Intercellular Mitochondrial Transfer Enhances the Antitumor Immunity of CD8+ T Cells
  di: Ce Guo, et al.
  Pubblicazione: (2025)